Wei-qi Lu
180 Fenglin Road
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Retraction Note: Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma.
Journal: Nature communications
Published: August 06, 2026
Dedifferentiated Liposarcoma Presenting as Primary Diffuse Peritoneal Sarcomatosis: A Case Report and Literature Review.
Journal: Journal of gastrointestinal cancer
Published: April 08, 2026
Nomogram development and external validation for predicting overall survival and cancer-specific survival in patients with primary retroperitoneal sarcoma: a retrospective cohort study.
Journal: Discover oncology
Published: May 20, 2023
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma.
Journal: Nature communications
Published: April 29, 2023
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 15, 2022
A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study.
Journal: Annals of translational medicine
Published: June 15, 2022
Management of retroperitoneal sarcoma involving the iliac artery: Single-center surgical experience.
Management of retroperitoneal sarcoma involving the iliac artery: Single-center surgical experience.
Journal: World journal of clinical cases
Published: June 09, 2021
Overexpression of DSCR1 prevents proliferation and predicts favorable prognosis in colorectal cancer patients.
Journal: World journal of surgical oncology
Published: December 08, 2020
Surgical treatment strategies for extra-pelvic intravenous leiomyomatosis.
Journal: Orphanet journal of rare diseases
Published: January 27, 2020
Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma.
Journal: Cancer medicine
Published: April 19, 2019
Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3.
Journal: Cell death & disease
Published: February 07, 2019
Last Updated: 09/26/2026